Cargando…

Retraction Note: CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo

Detalles Bibliográficos
Autores principales: Qi, Zhi-Ying, Wang, Fang, Yue, Ying-Ying, Guo, Xue-Wang, Guo, Rui-Meng, Li, Hong-Lin, Xu, Yan-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463306/
https://www.ncbi.nlm.nih.gov/pubmed/37626400
http://dx.doi.org/10.1186/s13048-023-01267-2
_version_ 1785098199907696640
author Qi, Zhi-Ying
Wang, Fang
Yue, Ying-Ying
Guo, Xue-Wang
Guo, Rui-Meng
Li, Hong-Lin
Xu, Yan-Ying
author_facet Qi, Zhi-Ying
Wang, Fang
Yue, Ying-Ying
Guo, Xue-Wang
Guo, Rui-Meng
Li, Hong-Lin
Xu, Yan-Ying
author_sort Qi, Zhi-Ying
collection PubMed
description
format Online
Article
Text
id pubmed-10463306
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104633062023-08-30 Retraction Note: CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo Qi, Zhi-Ying Wang, Fang Yue, Ying-Ying Guo, Xue-Wang Guo, Rui-Meng Li, Hong-Lin Xu, Yan-Ying J Ovarian Res Retraction Note BioMed Central 2023-08-25 /pmc/articles/PMC10463306/ /pubmed/37626400 http://dx.doi.org/10.1186/s13048-023-01267-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Retraction Note
Qi, Zhi-Ying
Wang, Fang
Yue, Ying-Ying
Guo, Xue-Wang
Guo, Rui-Meng
Li, Hong-Lin
Xu, Yan-Ying
Retraction Note: CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo
title Retraction Note: CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo
title_full Retraction Note: CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo
title_fullStr Retraction Note: CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo
title_full_unstemmed Retraction Note: CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo
title_short Retraction Note: CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo
title_sort retraction note: cypa promotes the progression and metastasis of serous ovarian cancer (soc) in vitro and in vivo
topic Retraction Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463306/
https://www.ncbi.nlm.nih.gov/pubmed/37626400
http://dx.doi.org/10.1186/s13048-023-01267-2
work_keys_str_mv AT qizhiying retractionnotecypapromotestheprogressionandmetastasisofserousovariancancersocinvitroandinvivo
AT wangfang retractionnotecypapromotestheprogressionandmetastasisofserousovariancancersocinvitroandinvivo
AT yueyingying retractionnotecypapromotestheprogressionandmetastasisofserousovariancancersocinvitroandinvivo
AT guoxuewang retractionnotecypapromotestheprogressionandmetastasisofserousovariancancersocinvitroandinvivo
AT guoruimeng retractionnotecypapromotestheprogressionandmetastasisofserousovariancancersocinvitroandinvivo
AT lihonglin retractionnotecypapromotestheprogressionandmetastasisofserousovariancancersocinvitroandinvivo
AT xuyanying retractionnotecypapromotestheprogressionandmetastasisofserousovariancancersocinvitroandinvivo